Antagonism by the suramin analogue NF279 on human P2X 1 and P2X 7 receptors

Author： Klapperstuck M.   Buttner C.   Nickel P.   Schmalzing G.   Lambrecht G.   Markwardt F.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.387, Iss.3, 2000-01, pp. : 245-252

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dissecting Individual Current Components of Co-expressed Human P2X1 and P2X7 Receptors

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 16, 2004-12 ,pp. : 1719-1730

Bentham Science Publishers

Access to resources Recommend Favorite

NF449, a novel picomolar potency antagonist at human P2X 1 receptors

By Hulsmann M.   Nickel P.   Kassack M.   Schmalzing G.   Lambrecht G.   Markwardt F.  

European Journal of Pharmacology, Vol. 470, Iss. 1, 2003-05 ,pp. : 1-7

Elsevier

Access to resources Recommend Favorite

P2X7 receptor antagonism in the treatment of cancers

By Roger Séébastien   Pelegrin Pablo  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 7, 2011-07 ,pp. : 875-880

Informa Healthcare

Access to resources Recommend Favorite

NF279: a novel potent and selective antagonist of P2X receptor-mediated responses

By Damer S.   Niebel B.   Czeche S.   Nickel P.   Ardanuy U.   Schmalzing G.   Rettinger J.   Mutschler E.   Lambrecht G.  

European Journal of Pharmacology, Vol. 350, Iss. 1, 1998-05 ,pp. : 5-6

Elsevier

Access to resources Recommend Favorite

P2X Receptors and Inflammation

By  

Current Medicinal Chemistry, Vol. 22, Iss. 7, 2015-03 ,pp. : 866-877

Bentham Science Publishers

Access to resources Recommend Favorite